| Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer JF Gainor, L Dardaei, S Yoda, L Friboulet, I Leshchiner, R Katayama, ... Cancer discovery 6 (10), 1118-1133, 2016 | 1121 | 2016 |
| Landscape of Acquired Resistance to Osimertinib in EGFR-Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for … Z Piotrowska, H Isozaki, JK Lennerz, JF Gainor, IT Lennes, VW Zhu, ... Cancer discovery 8 (12), 1529-1539, 2018 | 394 | 2018 |
| Impact of EML4-ALK Variant on Resistance Mechanisms and Clinical Outcomes in ALK-Positive Lung Cancer JJ Lin, VW Zhu, S Yoda, BY Yeap, AB Schrock, I Dagogo-Jack, NA Jessop, ... Journal of Clinical Oncology 36 (12), 1199-1206, 2018 | 308 | 2018 |
| Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound ALK Mutations in ALK-Positive Lung Cancer S Yoda, JJ Lin, MS Lawrence, BJ Burke, L Friboulet, A Langenbucher, ... Cancer discovery 8 (6), 714-729, 2018 | 278 | 2018 |
| RET solvent front mutations mediate acquired resistance to selective RET inhibition in RET-driven malignancies BJ Solomon, L Tan, JJ Lin, SQ Wong, S Hollizeck, K Ebata, BB Tuch, ... Journal of Thoracic Oncology 15 (4), 541-549, 2020 | 227 | 2020 |
| Activation of the FGF2-FGFR1 autocrine pathway: a novel mechanism of acquired resistance to gefitinib in NSCLC H Terai, K Soejima, H Yasuda, S Nakayama, J Hamamoto, D Arai, ... Molecular cancer research 11 (7), 759-767, 2013 | 221 | 2013 |
| Preparation of liposomes using an improved supercritical reverse phase evaporation method K Otake, T Shimomura, T Goto, T Imura, T Furuya, S Yoda, Y Takebayashi, ... Langmuir 22 (6), 2543-2550, 2006 | 204 | 2006 |
| SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors L Dardaei, HQ Wang, M Singh, P Fordjour, KX Shaw, S Yoda, G Kerr, ... Nature medicine 24 (4), 512-517, 2018 | 189 | 2018 |
| Chitosan aerogels: transparent, flexible thermal insulators S Takeshita, S Yoda Chemistry of Materials 27 (22), 7569-7572, 2015 | 186 | 2015 |
| Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer JJ Lin, SV Liu, CE McCoach, VW Zhu, AC Tan, S Yoda, J Peterson, A Do, ... Annals of Oncology 31 (12), 1725-1733, 2020 | 173 | 2020 |
| Preparation of a platinum and palladium/polyimide nanocomposite film as a precursor of metal-doped carbon molecular sieve membrane via supercritical impregnation S Yoda, A Hasegawa, H Suda, Y Uchimaru, K Haraya, T Tsuji, K Otake Chemistry of materials 16 (12), 2363-2368, 2004 | 170 | 2004 |
| MET alterations are a recurring and actionable resistance mechanism in ALK-positive lung cancer I Dagogo-Jack, S Yoda, JK Lennerz, A Langenbucher, JJ Lin, MM Rooney, ... Clinical Cancer Research 26 (11), 2535-2545, 2020 | 152 | 2020 |
| Tracking the evolution of resistance to ALK tyrosine kinase inhibitors through longitudinal analysis of circulating tumor DNA I Dagogo-Jack, AR Brannon, LA Ferris, CD Campbell, JJ Lin, KR Schultz, ... JCO precision oncology 2, 1-14, 2018 | 132 | 2018 |
| The new-generation selective ROS1/NTRK inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models R Katayama, BO Gong, N Togashi, M Miyamoto, M Kiga, S Iwasaki, ... Nature Communications 10 (1), 3604, 2019 | 124 | 2019 |
| Silver nanoparticle impregnated polycarbonate substrates for surface enhanced Raman spectroscopy T Hasell, L Lagonigro, AC Peacock, S Yoda, PD Brown, PJA Sazio, ... Advanced Functional Materials 18 (8), 1265-1271, 2008 | 113 | 2008 |
| Preparation of a W/scCO2 Microemulsion Using Fluorinated Surfactants M Sagisaka, S Yoda, Y Takebayashi, K Otake, B Kitiyanan, Y Kondo, ... Langmuir 19 (2), 220-225, 2003 | 111 | 2003 |
| Molecular mechanisms of resistance to first-and second-generation ALK inhibitors in ALK-rearranged lung cancer. Cancer Discov. 2016; 6: 1118–1133. doi: 10.1158/2159-8290 JF Gainor, L Dardaei, S Yoda, L Friboulet, I Leshchiner, R Katayama, ... CD-16-0596.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 109 | |
| Recovery of constituent monomers from polyethylene terephthalate with supercritical methanol T Sako, I Okajima, T Sugeta, K Otake, S Yoda, Y Takebayashi, ... Polymer journal 32 (2), 178-181, 2000 | 99 | 2000 |
| Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in ROS1 Fusion–Positive Lung Cancer JJ Lin, NJ Choudhury, S Yoda, VW Zhu, TW Johnson, R Sakhtemani, ... Clinical Cancer Research 27 (10), 2899-2909, 2021 | 85 | 2021 |
| Interfacial Properties of Branch-Tailed Fluorinated Surfactants Yielding a Water/Supercritical CO2 Microemulsion M Sagisaka, T Fujii, Y Ozaki, S Yoda, Y Takebayashi, Y Kondo, N Yoshino, ... Langmuir 20 (7), 2560-2566, 2004 | 85 | 2004 |
